The Chemacopia team
The Chemacopia team
• Hitesh Patel PhD; 26 yrs. Pharma, Biotech & CRO/CDMO experience; Overseen multiple CNS & Oncology programs from discovery to FIM studies, co-inventor of launched AML drug Quizartinib
CRO/CDMO Strategy, R&D Operations, Business & Corporate Development, Seed Investment group with Consortium, VC and Private investors
• Meredith Williams PhD; Medicinal chemistry, 22 years in research and several senior roles including at Sai Life Sciences (India), S-Bio (Singapore), Pharmacia (Sweden) and Biovitrium
Oncology, Metabolic diseases, Outsourcing, R&D, Operations
_____________________________________________________________________________________________
• Kumar Penmetsa PhD; ~23 years Big Pharma and Biotech consulting/leadership experience; track record of proven results and deliverables
Strategy, Operations, Business Development & Licensing, Corporate Development
Oncology, Inflammation, Cardiovascular & Metabolic Diseases
• Teng Lin PhD; ~15 years Biotech, Healthcare and Insurance experience; track record of proven results and deliverables
Business Development, Corporate Development, R&D, Operation
_____________________________________________________________________________________________
• Extensive network of consultants spanning multiple disciplines
2021 Chemacopia - www.chemacopia.com